Stéphanie Baulac leads the "MOSAIC: Genetic Mosaicism in Epilepsy and Neurodevelopmental Disorders" team at the Paris Brain Institute (ICM). As INSERM Research Director (DR1), she obtained her PhD in neurogenetics from University Paris Cité in 2001, followed by a postdoctoral fellowship at Harvard Medical School (2002-2005) and a research stay at Kyoto University in Japan (2009-2010).

Her career has been distinguished by numerous prestigious awards: the Valérie Chamaillard Prize from the French Foundation for Epilepsy Research (2014), an ERC Consolidator Grant (2016), the Michael Prize - international award in epileptology (2019), the Camille Woringer Prize from the FRM (2019), the Grand Prix Robert Debré for medical research (2019), and the Lamonica Prize in Neurology from the French Academy of Sciences (2024).

She serves on the scientific board of the French League Against Epilepsy (LFCE) and the French Foundation for Epilepsy Research (FFRE).

With over 125 publications and more than 12,500 citations, her research has significantly contributed to understanding the genetic mechanisms of epilepsies, notably through the discovery of mutations in genes of the mTOR signaling pathway.